Dow Jones Futures Eye Iran Deal Catalysts Tesla Select AI Stocks at Potential Entry Levels Quantum Coast Capital Founder Matt Cimaglia Discusses 2 Billion Grant for Quantum Industry Telecoms CEO Warns Europe Faces Dangerous Dependency on US Satellites and AI Wipros Rs 15000 Crore Share Buyback at 23 Premium Key Details and Market Implications Eli Lilly Commits 4 Billion to Vaccine Development in Trio of Deals April Private Payrolls Rise 109000 Exceeding Expectations ADP Report Signals Steady Labor Market Silgan Holdings Inc SLGN Q1 2026 Earnings EPS Beats Estimates Amid Cautious Operating Environment ZGN Q4 2025 Earnings Strong EPS Beat Amid Revenue Discrepancies CATY Q1 2026 Earnings Strong EPS Beat as Cathay General Bancorp Delivers 2275 Surprise PFSI Q1 2026 Earnings EPS Miss of 385 Drags Shares Lower Amid Mortgage Market Headwinds JXN Q1 2026 Earnings EPS Misses Estimates Amid Market Uncertainty SBC Q1 2026 Earnings EPS Exceeds Estimates as Stock Dips Despite Strong Profitability AGNC Investment Corp AGNC Edges Higher Key Levels and Market Dynamics HeartSciences Inc Warrant HSCSW Slides 1550 as Price Narrows to 005 National Bank Holdings NBHC Slips 094 as Regional Banking Sentiment Softens Renasant Corporation RNST Holds Near 41 as Stock Consolidates Below Resistance VKI Edges Higher as Municipal Income Trust Maintains Stability Why Bonds May Not Protect Portfolios From InflationLed Market Shocks Morgan Stanleys 150Year Study Accuray ARAY Q1 2026 Earnings EPS Misses Estimates as Revenue Figures Remain Unreported Silvercorp Metals Shares Slide Over 4 Amid Broader Sector Weakness BlackBerry BB Surges 645 Key Levels and Potential Drivers Dorchester Minerals DMLP Sees Modest Decline Amidst Sector Volatility Key Support Levels Hold JBG SMITH Properties JBGS Edges Higher on Modest Gains Key Levels in Focus AEFC Edges Higher Amid Steady Trading Key Levels in Focus White Pearl Acquisition Corp WPAC Edges Higher as Price Consolidates Near Resistance Gladstone Investment 4875 Notes GAINZ Stability Amidst Flat Trading Yield Opportunity in Focus Coherus Oncology CHRS Rises 37 as Stock Approaches Resistance at 178